— Know what they know.
Not Investment Advice
Asset Manager ← All Institutions

ABG-WTT Global Life Science Capital Partners GP Ltd

Q2 2025 · Filed 2025-08-14
Market Value
$27M
-30.2%
Holdings
4
New Purchases
0
Added To
0
Closed
2
Reduced
0
Top 10 Concentration
100.0%
Turnover
50.0%

Top Buys (by % of Portfolio)

SymbolCur %Prior %Chg %Value
CBLL 76.17% 54.54% +21.62% $20M
RPID 23.83% 12.73% +11.10% $6M

Top Sells (by % of Portfolio)

SymbolCur %Prior %Chg %Value
CGON 0.00% 31.67% -31.67% $0
LUNG 0.00% 1.06% -1.06% $0

Sector Allocation Over Time

Market Cap Concentration

TierHoldingsValueWeight
Mid Cap 1 $0 0.0%
Small Cap 1 $20M 76.2%
Micro Cap 2 $6M 23.8%

Portfolio Analytics

Avg Market Cap
$1.6B
Median Market Cap
$403M
Avg P/E
Median P/E
Avg Dividend Yield
—%
Avg Beta
0.78
# Stocks
4
# ETFs / Funds
0

Top Holdings (4 total)

# Symbol % Port Shares Value Avg Price Q/Q Value Chg Share Chg Chg % Status
1 CBLL 76.17% 1,088,101 $20M $18.73 -$522K
2 RPID 23.83% 1,848,296 $6M $3.45 $1M
3 CGON —% -$12M -495,526 -100.0% SOLD
4 LUNG —% -$405K -60,204 -100.0% SOLD

Sold Out Positions

SymbolValue% Port
CGON —%
LUNG —%
View SEC EDGAR Filings for ABG-WTT Global Life Science Capital Partners GP Ltd →

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms